Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.3B | 11.5B | 11.9B | 11.8B |
Cost of revenue | 4.1B | 3.2B | 3.7B | 4.1B |
Gross profit | 8.1B | 8.3B | 8.1B | 7.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.2B | 4.3B | 4.3B | 4.1B |
Operating income | 2.0B | 1.9B | 1.9B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 260M | 420M | 420M | 370M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 1.8B | 1.7B | 1.5B |
Tax provision | 260M | 490M | 510M | 410M |
Net income | 1.9B | 1.3B | 1.2B | 1.1B |
Basic EPS | — | 11.5 | 11.0 | 9.8 |
Diluted EPS | — | 11.5 | 11.0 | 9.8 |
Basic average shares | — | 109.9M | 110.1M | 110.1M |
Diluted average shares | — | 109.9M | 110.1M | 110.1M |
EBITDA | 3.3B | 3.1B | 3.0B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |